Review



mouse antibody against stat3  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc mouse antibody against stat3
    Mouse Antibody Against Stat3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse antibody against stat3/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    mouse antibody against stat3 - by Bioz Stars, 2026-06
    86/100 stars

    Images



    Similar Products

    86
    Cell Signaling Technology Inc mouse antibody against stat3
    Mouse Antibody Against Stat3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse antibody against stat3/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    mouse antibody against stat3 - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc antibodies against stat 3
    Antibodies Against Stat 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against stat 3/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    antibodies against stat 3 - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc antibodies against stat3
    Antibodies Against Stat3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against stat3/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    antibodies against stat3 - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc antibodies against p stat3
    A Detection of RP11-54O7.17 subcellular localization by in situ hybridization, n = 3. B Subcellular localization of RP11-54O7.17 by nucleocytoplasmic separation assay, n = 3. C Schematic representation of related genes downstream of the SE region where RP11-54O7.17 is located. D Changes in SE-related downstream genes after RP11-54O7.17 overexpression detected by RT-qPCR assay, n = 3. E Analysis of transcription factors related to RP11-54O7.17 expression. F Effect of RP11-54O7.17 overexpression on <t>STAT3</t> cellular localization detected by immunofluorescence, n = 3. G Expression of p-STAT3 and STAT3 in RP11-54O7.17 overexpression TNBC cells detected by Western Blotting, n = 3. H Intranuclear and extranuclear STAT3 content in RP11-54O7.17 overexpressing cells detected by nucleocytoplasmic separation assay, n = 3. Data for ( B and D ) are presented as mean ± SD, * P < 0.05, ** P < 0.01.
    Antibodies Against P Stat3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against p stat3/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    antibodies against p stat3 - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc antibodies against stat3 9139s
    A Detection of RP11-54O7.17 subcellular localization by in situ hybridization, n = 3. B Subcellular localization of RP11-54O7.17 by nucleocytoplasmic separation assay, n = 3. C Schematic representation of related genes downstream of the SE region where RP11-54O7.17 is located. D Changes in SE-related downstream genes after RP11-54O7.17 overexpression detected by RT-qPCR assay, n = 3. E Analysis of transcription factors related to RP11-54O7.17 expression. F Effect of RP11-54O7.17 overexpression on <t>STAT3</t> cellular localization detected by immunofluorescence, n = 3. G Expression of p-STAT3 and STAT3 in RP11-54O7.17 overexpression TNBC cells detected by Western Blotting, n = 3. H Intranuclear and extranuclear STAT3 content in RP11-54O7.17 overexpressing cells detected by nucleocytoplasmic separation assay, n = 3. Data for ( B and D ) are presented as mean ± SD, * P < 0.05, ** P < 0.01.
    Antibodies Against Stat3 9139s, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against stat3 9139s/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    antibodies against stat3 9139s - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc antibodies against total stat3
    Hepatic inflammatory signaling was enhanced in the central fatigue group. Representative immunoblots of pSTAT3 tyr705 , <t>STAT3,</t> and α‐tubulin in liver lysates in each fatigue group (Panel a) and their densitometries (Panels b and c) ( n = 6). Levels of IL‐6 in the liver lysate in each fatigue group were evaluated (panel d) ( n = 6). Significant differences between groups were evaluated by two‐way ANOVA followed by Tukey's honestly significant difference test. pSTAT3 tyr705 : Phosphorylated signal transducers and activator of transcription 3 at tyrosine 705. IL‐6, interleukin‐6; STAT3, signal transducers and activator of transcription 3.
    Antibodies Against Total Stat3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against total stat3/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    antibodies against total stat3 - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    Image Search Results


    A Detection of RP11-54O7.17 subcellular localization by in situ hybridization, n = 3. B Subcellular localization of RP11-54O7.17 by nucleocytoplasmic separation assay, n = 3. C Schematic representation of related genes downstream of the SE region where RP11-54O7.17 is located. D Changes in SE-related downstream genes after RP11-54O7.17 overexpression detected by RT-qPCR assay, n = 3. E Analysis of transcription factors related to RP11-54O7.17 expression. F Effect of RP11-54O7.17 overexpression on STAT3 cellular localization detected by immunofluorescence, n = 3. G Expression of p-STAT3 and STAT3 in RP11-54O7.17 overexpression TNBC cells detected by Western Blotting, n = 3. H Intranuclear and extranuclear STAT3 content in RP11-54O7.17 overexpressing cells detected by nucleocytoplasmic separation assay, n = 3. Data for ( B and D ) are presented as mean ± SD, * P < 0.05, ** P < 0.01.

    Journal: Cell Death & Disease

    Article Title: Super enhancer lncRNA RP11-54O7.17 regulates the proliferation and metastasis of triple-negative breast cancer by targeting lysosomal degradation of S100A4

    doi: 10.1038/s41419-025-08072-3

    Figure Lengend Snippet: A Detection of RP11-54O7.17 subcellular localization by in situ hybridization, n = 3. B Subcellular localization of RP11-54O7.17 by nucleocytoplasmic separation assay, n = 3. C Schematic representation of related genes downstream of the SE region where RP11-54O7.17 is located. D Changes in SE-related downstream genes after RP11-54O7.17 overexpression detected by RT-qPCR assay, n = 3. E Analysis of transcription factors related to RP11-54O7.17 expression. F Effect of RP11-54O7.17 overexpression on STAT3 cellular localization detected by immunofluorescence, n = 3. G Expression of p-STAT3 and STAT3 in RP11-54O7.17 overexpression TNBC cells detected by Western Blotting, n = 3. H Intranuclear and extranuclear STAT3 content in RP11-54O7.17 overexpressing cells detected by nucleocytoplasmic separation assay, n = 3. Data for ( B and D ) are presented as mean ± SD, * P < 0.05, ** P < 0.01.

    Article Snippet: Primary antibodies in the study were antibodies against p-STAT3 (1:1000, Cst, #4113), STAT3 (1:1000, Cst, #30835), S100A4 (1:1000, Cst, #13018), HSP70 (1:1000, Santa Cruz, #K2020), GAPDH (1:1000, Cst, #5174), β-tubulin (1:1000, Cst, #2128) and H3 (1:1000, Millipore, #06-599).

    Techniques: In Situ Hybridization, Over Expression, Quantitative RT-PCR, Expressing, Immunofluorescence, Western Blot

    A Expression of S100A4 and p-STAT3 in RP11-54O7.17 overexpressed cells detected by Western blotting, n = 3. B Expression of S100A4 in RP11-54O7.17 overexpressed cells detected by immunofluorescence (White arrows: S100A4 nucleoli enrichment, DAPI micronuclei), n = 3. C Expression of S100A4 in cells transfected with different concentrations of RP11-54O7.17 in vitro, n = 3. D Effect of S100A4 overexpression on the inhibition of cell clone formation induced by RP11-54O7.17 by colony formation assay, n = 3. E Effect of S100A4 overexpression on the inhibition of cell viability induced by RP11-54O7.17 by MTT assay, n = 3. F Effect of S100A4 knocked-down on STAT3 activation, n = 3. G Effect of S100A4 overexpression on STAT3 activation, n = 3. Data for ( D , E ) are presented as mean ± SD, ** P < 0.01, *** P < 0.001.

    Journal: Cell Death & Disease

    Article Title: Super enhancer lncRNA RP11-54O7.17 regulates the proliferation and metastasis of triple-negative breast cancer by targeting lysosomal degradation of S100A4

    doi: 10.1038/s41419-025-08072-3

    Figure Lengend Snippet: A Expression of S100A4 and p-STAT3 in RP11-54O7.17 overexpressed cells detected by Western blotting, n = 3. B Expression of S100A4 in RP11-54O7.17 overexpressed cells detected by immunofluorescence (White arrows: S100A4 nucleoli enrichment, DAPI micronuclei), n = 3. C Expression of S100A4 in cells transfected with different concentrations of RP11-54O7.17 in vitro, n = 3. D Effect of S100A4 overexpression on the inhibition of cell clone formation induced by RP11-54O7.17 by colony formation assay, n = 3. E Effect of S100A4 overexpression on the inhibition of cell viability induced by RP11-54O7.17 by MTT assay, n = 3. F Effect of S100A4 knocked-down on STAT3 activation, n = 3. G Effect of S100A4 overexpression on STAT3 activation, n = 3. Data for ( D , E ) are presented as mean ± SD, ** P < 0.01, *** P < 0.001.

    Article Snippet: Primary antibodies in the study were antibodies against p-STAT3 (1:1000, Cst, #4113), STAT3 (1:1000, Cst, #30835), S100A4 (1:1000, Cst, #13018), HSP70 (1:1000, Santa Cruz, #K2020), GAPDH (1:1000, Cst, #5174), β-tubulin (1:1000, Cst, #2128) and H3 (1:1000, Millipore, #06-599).

    Techniques: Expressing, Western Blot, Immunofluorescence, Transfection, In Vitro, Over Expression, Inhibition, Colony Assay, MTT Assay, Activation Assay

    A RP11-54O7.17 Liposome delivery modality. B Changes in nude mice body weight after RP11-54O7.17 liposome injection, n = 6. C Images of subcutaneous tumors, n = 6. D Weight of subcutaneous tumors, n = 6. E Changes in subcutaneous tumor volume, n = 6. F Content of RP11-54O7.17 tumor tissue, n = 6. G Expression of S100A4, p-STAT3 and Ki-67 in tumor tissues detected by immunohistochemistry, n = 3. H Expression of p-STAT3 and S100A4 in tumor tissues detected by Western blotting, n = 3. I Expression of LC3B and P62 in tumor tissues detected by Western blotting, n = 3. Data for ( B , D , E , and F ) are presented as mean ± SD, * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: Cell Death & Disease

    Article Title: Super enhancer lncRNA RP11-54O7.17 regulates the proliferation and metastasis of triple-negative breast cancer by targeting lysosomal degradation of S100A4

    doi: 10.1038/s41419-025-08072-3

    Figure Lengend Snippet: A RP11-54O7.17 Liposome delivery modality. B Changes in nude mice body weight after RP11-54O7.17 liposome injection, n = 6. C Images of subcutaneous tumors, n = 6. D Weight of subcutaneous tumors, n = 6. E Changes in subcutaneous tumor volume, n = 6. F Content of RP11-54O7.17 tumor tissue, n = 6. G Expression of S100A4, p-STAT3 and Ki-67 in tumor tissues detected by immunohistochemistry, n = 3. H Expression of p-STAT3 and S100A4 in tumor tissues detected by Western blotting, n = 3. I Expression of LC3B and P62 in tumor tissues detected by Western blotting, n = 3. Data for ( B , D , E , and F ) are presented as mean ± SD, * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: Primary antibodies in the study were antibodies against p-STAT3 (1:1000, Cst, #4113), STAT3 (1:1000, Cst, #30835), S100A4 (1:1000, Cst, #13018), HSP70 (1:1000, Santa Cruz, #K2020), GAPDH (1:1000, Cst, #5174), β-tubulin (1:1000, Cst, #2128) and H3 (1:1000, Millipore, #06-599).

    Techniques: Injection, Expressing, Immunohistochemistry, Western Blot

    RP11-54O7.17 is low-expressed and destabilized in TNBC cells, and the RP11-54O7.17 overexpression enhances the interaction of S100A4 with HSP70, promoting the autophagy-lysosome degradation of S100A4, which in turn suppresses the transcription of STAT3 downstream oncogenes.

    Journal: Cell Death & Disease

    Article Title: Super enhancer lncRNA RP11-54O7.17 regulates the proliferation and metastasis of triple-negative breast cancer by targeting lysosomal degradation of S100A4

    doi: 10.1038/s41419-025-08072-3

    Figure Lengend Snippet: RP11-54O7.17 is low-expressed and destabilized in TNBC cells, and the RP11-54O7.17 overexpression enhances the interaction of S100A4 with HSP70, promoting the autophagy-lysosome degradation of S100A4, which in turn suppresses the transcription of STAT3 downstream oncogenes.

    Article Snippet: Primary antibodies in the study were antibodies against p-STAT3 (1:1000, Cst, #4113), STAT3 (1:1000, Cst, #30835), S100A4 (1:1000, Cst, #13018), HSP70 (1:1000, Santa Cruz, #K2020), GAPDH (1:1000, Cst, #5174), β-tubulin (1:1000, Cst, #2128) and H3 (1:1000, Millipore, #06-599).

    Techniques: Over Expression

    Hepatic inflammatory signaling was enhanced in the central fatigue group. Representative immunoblots of pSTAT3 tyr705 , STAT3, and α‐tubulin in liver lysates in each fatigue group (Panel a) and their densitometries (Panels b and c) ( n = 6). Levels of IL‐6 in the liver lysate in each fatigue group were evaluated (panel d) ( n = 6). Significant differences between groups were evaluated by two‐way ANOVA followed by Tukey's honestly significant difference test. pSTAT3 tyr705 : Phosphorylated signal transducers and activator of transcription 3 at tyrosine 705. IL‐6, interleukin‐6; STAT3, signal transducers and activator of transcription 3.

    Journal: Physiological Reports

    Article Title: Plasma hepcidin level is elevated by water immersion‐induced central fatigue via hepatic inflammatory response in male and female rats

    doi: 10.14814/phy2.70468

    Figure Lengend Snippet: Hepatic inflammatory signaling was enhanced in the central fatigue group. Representative immunoblots of pSTAT3 tyr705 , STAT3, and α‐tubulin in liver lysates in each fatigue group (Panel a) and their densitometries (Panels b and c) ( n = 6). Levels of IL‐6 in the liver lysate in each fatigue group were evaluated (panel d) ( n = 6). Significant differences between groups were evaluated by two‐way ANOVA followed by Tukey's honestly significant difference test. pSTAT3 tyr705 : Phosphorylated signal transducers and activator of transcription 3 at tyrosine 705. IL‐6, interleukin‐6; STAT3, signal transducers and activator of transcription 3.

    Article Snippet: After blocking with TBS containing 0.005% Tween 20 and 5% milk, the membranes were incubated overnight with primary antibodies against total Stat3 (#9139, Cell Signaling, RRID:AB_331757, 1:1000 dilution), phospho‐Stat3 (Tyr705) (#9145, Cell Signaling, RRID:AB_2491009, 1:1000 dilution), and α‐Tubulin (#ab4074, Abcam, RRID:AB_2288001, 1:10000 dilution).

    Techniques: Western Blot